Hyaluronic acid-coated bovine serum albumin nanoparticles loaded with brucine as selective nanovectors for intra-articular injection

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3843-3853

  Chen, Zhipeng ^a   Chen, Juan ^a   Wu, Li ^a   Li, Weidong ^a   Chen, Jun ^a   Cheng, Haibo ^a   Pan, Jinhuo ^a   Cai, Baochang ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Bsa; Chondrocyte; Hyaluronic acid; Intra articular injection; Nanoparticles

Indexed keywords

BOVINE SERUM ALBUMIN; BOVINE SERUM ALBUMIN NANOPARTICLE; BRUCINE; HYALURONIC ACID; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; CARTILAGE CELL; CAVEOLAE MEDIATED ENDOCYTOSIS; CLATHRIN MEDIATED ENDOCYTOSIS; COATED PARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DYNAMIC LIGHT SCATTERING; ENDOCYTOSIS; FLUORESCENCE IMAGING; HYPERPLASIA; IN VIVO STUDY; JOINT CAVITY; LIGHT SCATTERING; MALE; NONHUMAN; PINOCYTOSIS; RAT; SYNOVIUM; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

BSA; CHONDROCYTE; HYALURONIC ACID; INTRA-ARTICULAR INJECTION; NANOPARTICLES;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; CHONDROCYTES; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; JOINTS; MALE; NANOCAPSULES; RABBITS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN, BOVINE; STRYCHNINE; TISSUE DISTRIBUTION;

EID: 84885698295     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S50721     Document Type: Article

References (22)

1. Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev. 2006;58(2):226-242.
2. Sarzi-Puttini P, Cimmino MA, Scarpa R, et al. Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum. 2005;35(1 Suppl 1):1-10.
3. Albert C, Brocq O, Gerard D, Roux C, Euller-Ziegler L. Septic knee arthritis after intra-articular hyaluronate injection. Two case reports. Joint Bone Spine. 2006;73(2):205-207.
4. Zhao D, Zhao X, Zu Y, et al. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine. 2010;5:669-677.
5. Temming K, Meyer DL, Zabinski R. Improved efficacy αvβ3-targeted albumin conjugates by conjugation of a novel auristatin derivative. Mol Pharm. 2007;4(5):686-694.
6. Fang YW, Yin ZN. Preparation of a hyaluronic acid modified bovine serum albumin nanoparticle and its anti-tumor effect. Sichuan Da Xue Xue Bao Yi Xue Ban. 2011;42(4):480-484. Chinese.
7. Green MR, Manikhas GM, Orlov S, et al. Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Ann Oncol. 2006;17(8): 1263-1268.
8. Miele E, Spinelli GP, Miele E, Tomao F, Tomao S. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomedicine. 2009;4:99-105.
9. Laurent TC, Dahl IM, Dahl LB, et al. The catabolic fate of hyaluronic acid. Connect Tissue Res. 1986;15(1-2):33-41.
10. Smedsrod B. Cellular events in the uptake and degradation of hyaluronan. Adv Drug Deliv Rev. 1991;7(2):265-278.
11. Fraser JR, Laurent TC, Engström-Laurent A, Laurent UG. Elimination of hyaluronic acid from the blood stream in the human. Clin Exp Pharmacol Physiol. 1984;11(1):17-25.
12. Cai BC, Chen L, Kadota S, Hattori M, Namba T. Processing of nux vomica IV. A comparison of cytotoxicity of nine alkaloids from processed seeds of Strychnos nux-vomica on tumor cell lines. Nat Med. 1995;49:39-42.
13. Cai BC, Wang TS, Kurokawa M. Cytotoxicities of alkaloids from processed and unprocessed seeds of Strychnos nux-vomica. Acta Pharmacol Sin. 1998;19(5):425-428.
14. Rao PS, Ramanadham M, Prasad MN. Anti-proliferative and cytotoxic effects of Strychnos nux-vomica root extract on human multiple myeloma cell line-RPMI 8226. Food Chem Toxicol. 2009;47(2): 283-288.
15. Agrawal SS, Saraswati S, Mathur R, Pandey M. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line. Life Sci. 2011;89(5-6):147-158.
16. Zhang M, Li P, Wang J, Zhai ZM. Effects of brucine on nitric oxide induced apoptosis in chondrocyte [J]. Chinese J of Clinical Rehabilitation. 2003;7:3554-3556.
17. Mousavi SA, Malerød L, Berg T, Kjeken R. Clathrin-dependent endocytosis. Biochem J. 2004;377(Pt 1):1-16.
18. Chen ZP, Xiao L, Liu D, et al. Synthesis of a novel polymer cholesterol-poly(ethylene glycol) 2000-glycyrrhetinic acid (Chol-PEG-GA) and its application in brucine liposome. J Appl Polym Sci. 2012;124(6):4554-4563.
19. Chiu YL, Ho YC, Chen YM, et al. The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan. J Control Release. 2010;146(1):152-159.
20. Nam HY, Kwon SM, Chung H, et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2009;135(3):259-267.
21. Perumal OP, Inapagolla R, Kannan S, Kannan RM. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials. 2008;29(24-25):3469-3476.
22. Liu C, Yu W, Chen Z, Zhang J, Zhang N. Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis. J Control Release. 2011;151(2):162-175.